These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3900488)

  • 1. [Leukocyte adherence inhibition (LAI) test in patients with chronic liver diseases].
    Matsumoto Y; Ishihara J; Yamamoto M
    Rinsho Byori; 1985 Apr; 33(4):421-5. PubMed ID: 3900488
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leukocyte adherence inhibition test (LAI): instrumentation, procedure and possibilities for use].
    Lehmitz R; Grap H; Schulze H; Ziegler K
    Z Med Lab Diagn; 1982 Jan; 23(1):49-54. PubMed ID: 7046275
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leukocyte adherence inhibition test (LAI)].
    Matsumoto Y
    Rinsho Byori; 1981 Apr; (Suppl 45):250-64. PubMed ID: 7026839
    [No Abstract]   [Full Text] [Related]  

  • 5. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer.
    Horváth M; Tóth L; Tóth J; Fekete B
    Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Some methodical aspects of the leukocyte adherence inhibition test (LAI)].
    Teuber S; Storch H
    Z Med Lab Diagn; 1986; 27(3):169-73. PubMed ID: 3524045
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic characteristics of the leukocyte adherence inhibition assay in rheumatoid arthritis.
    Tannenbaum H; Wild J
    Clin Invest Med; 1983; 6(3):153-9. PubMed ID: 6360455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of vaginal hormonal cytology and the leukocyte adherence inhibition test for the detection of malignancy.
    Kobilková J; Jandová A; Motlík K; Coupek J; Heyberger K
    Acta Cytol; 1983; 27(4):417-20. PubMed ID: 6349199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
    Mounielou PM; Clemente F; Estival A; Ribet A
    Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of MS associated factors for test procedures in multiple sclerosis: 2. Angers' MS-induced substance in the LAI test].
    Lehmitz R; Meyer U; Meyer-Rienecker HJ
    Psychiatr Neurol Med Psychol (Leipz); 1983 Dec; 35(12):714-9. PubMed ID: 6366844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tube LAI assay in diagnosis and monitoring of a cancer disease.
    Hasek M; Holán V; Kousalová M
    Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive value of immunological studies in patients with maxillofacial malignancies. 1. Leukocyte adherence inhibition tests (LAI)].
    Teuber S; Storch H; Gitt HA
    Stomatol DDR; 1984 May; 34(5):266-72. PubMed ID: 6382696
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
    De Carli HO; Restbergs V
    Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
    Kotlar HK; Sanner T
    J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modification of leucocyte adherence inhibition (LAI) assay with 51Cr-labelled leucocytes (author's transl)].
    Varga A; Stosiek P; Kasper M
    Allerg Immunol (Leipz); 1980; 26(2):171-8. PubMed ID: 6449844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of "rheumatoid neoantigen-like material" in urine of patients with RA, demonstrated by use of leukocyte adherence inhibition assay.
    Tannenbaum H
    J Rheumatol Suppl; 1983 Dec; 11():97-102. PubMed ID: 6366224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of tube LAI assay in larynx cancer patients.
    Hasek M; Holán V; Síbl O; Kousalová M
    Neoplasma; 1981; 28(6):685-8. PubMed ID: 7040994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Test-tube LAI test in the diagnosis of malignant melanoma].
    Hasek M; Holán V; Duchková H; Kubíková M; Sibl O; Kousalová M
    Cesk Dermatol; 1982 Jun; 57(3):161-3. PubMed ID: 6749310
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tumor immunity and the LAI test].
    Hasek M
    Cesk Dermatol; 1980 Aug; 55(4):263-5. PubMed ID: 6996845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.